What a Generative AI FTO Review Actually Determines
A generative AI freedom-to-operate review asks whether a proposed AI product, service, or business deployment can practice certain claims in a particular country without infringing enforceable patents, copyrights, trade secrets, or contractual restrictions. It does not establish that the product “owns” freedom to operate everywhere, and it is not the same as receiving a patentability opinion. Patentability asks whether an applicant should pursue a new patent; FTO asks whether an existing product or planned activity may fall within someone else’s rights. The review should therefore connect each material technical feature to potentially relevant rights and then assess legal risk in the intended jurisdictions.
Also worth reading: What Are the Main Generative AI Patent Litigation Trends in 2026? · How Should Patent Portfolios Be Structured to Maintain EU Compliance in the Age of Generative AI? · How Can Patent Practitioners Effectively Manage Risks When Using Generative AI for Drafting?
For generative AI, the analysis is unusually broad because a product may involve model training, licensed or scraped data, synthetic-data generation, human feedback, retrieval-augmented generation, agentic tools, output filtering, cloud infrastructure, and an application-specific interface. Each layer may implicate different patent families, copyright records, licenses, and confidential-information obligations. A defensible review is product-specific, jurisdiction-specific, and time-stamped. A 2026 report that merely names popular foundation models or cites a patent database is useful preliminary research, but it is not a complete FTO analysis.
Why Generative AI Creates More Complicated FTO Exposure
Generative AI combines patent questions with unsettled copyright, contract, and trade-secret questions. Patent claims may describe model architecture, attention mechanisms, training techniques, optimization, quantization, retrieval, inference orchestration, multimodal processing, or an application workflow. Copyright may concern source material, model outputs, voice or likeness rights, dataset licensing, and contractual terms governing data providers. Because these areas do not resolve in one body of law, companies should maintain separate issue tracks and document uncertainty rather than collapse every concern into a single infringement percentage.
The legal position can also change quickly. The United States’ January 23, 2025 Executive Order 14179 directed federal policy toward removing barriers to American AI leadership and reviewing prior executive-branch AI policies. That political direction did not itself create new patent rights or determine copyright infringement, but it illustrates why an AI review must include policy monitoring. Similarly, litigation involving AI-generated material, training data, publicity rights, and copyright authorship can affect business decisions even when no patent claim has yet been asserted. The correct approach is to distinguish enacted law, judicial decisions, agency guidance, pending litigation, and commercial policy.
AI FTO also differs by the activity being evaluated. An internal research prototype, a customer-facing chatbot, an automated coding assistant, and an AI system that makes medical decisions do not present the same deployment, contracting, or regulatory profile. The relevant question is not simply “Does the company use AI?” but “Which claims, contracts, data rights, and regulated uses attach to this particular product and market entry plan?” This narrower formulation makes the review more reliable and reduces unnecessary expenditure on claims that have no technical or commercial nexus to the product.
The Seven-Stage Review Process
The first stage defines the product with enough precision to analyze. Counsel should obtain an architecture description, data-flow diagram, list of third-party models and services, release plan, target countries, expected users, and planned business model. Dates matter because versions and features change quickly. The team should preserve a baseline, such as a v1.5 model with retrieval and a voice interface scheduled for launch on October 15, 2026, rather than describing it only as “our multimodal AI platform.” Each later FTO decision can then be tied to an identifiable configuration.
The second stage creates an initial claim map based on the product’s actual features. A useful map links a feature, such as reranking retrieved passages before answer generation, to the relevant claim language, patent family, jurisdiction, owner, filing date, expiration date, and asserted or likely status. Keyword searches alone are weak because patent vocabulary often differs from engineering terminology. A technical expert should help translate concepts such as mixture-of-experts routing, reinforcement learning from human feedback, speculative decoding, embeddings, and tool invocation into concrete functions.
The third stage searches authoritative and commercial patent sources and then validates the results. Search should cover published applications, granted claims, continuations, divisionals, continuations-in-part, assignments, and maintenance information. US patent applications ordinarily publish after 18 months, and patent term and enforceability require individual legal analysis; an earlier filing does not automatically mean a patent remains valid in 2026. Counsel should also search related non-patent sources, including copyright records, model and dataset agreements, privacy policies, terms of service, open-source licenses, and restrictions associated with voices, images, and training data.
The fourth stage performs a claim-by-claim technical and legal assessment. For each potentially relevant independent claim, the team should ask whether every limitation occurs literally or under an applicable doctrine in the target jurisdiction. A feature-level resemblance is not enough: limitation coverage, claim construction, prosecution history, priority, validity, exhaustion, implied license, and other defenses may control the outcome. High-risk claims should receive a design-around analysis, validity review, or both. The report should state assumptions and unresolved factual questions instead of presenting a retrieved patent as a certain blocker.
The fifth stage evaluates alternatives. Some risk can be reduced by changing the model architecture, replacing a dataset, removing a particular inference optimization, using a supplier with stronger license representations, restricting a launch country, or obtaining a license. Not every identified patent is economically or legally relevant. A small-company feature may carry lower cost than redesign, while a core platform feature used in 12 countries could justify expedited senior review. Risk scoring should combine legal exposure with technical centrality, market value, remaining patent term, design difficulty, and the cost of delay.
The sixth stage documents conclusions and decision gates. The report should distinguish “no relevant rights identified,” “potentially relevant rights identified,” “material uncertainty remains,” and “active redesign recommended.” These are more useful than an unsupported statement that a product is 90% safe. Counsel should record search dates, databases used, reviewers, jurisdictions, product versions, claim charts, and sources of factual information. A launch-critical unknown should be assigned an owner and deadline, such as resolving the training-data provenance issue by September 10 or commissioning an independent claim construction analysis by September 20.
The seventh stage continues after launch. Patent landscapes, ownership, validity, claim scope, contracts, and litigation change over time. An effective monitoring program can use alerts for relevant assignees, claim amendments, continuation activity, publications, and legal developments. AI vendors may also update models, datasets, indemnification terms, or service restrictions without changing the customer-facing product name. A quarterly review may suit a stable enterprise application, while a product deploying new agents or model capabilities monthly may need monthly checks for material changes.
Patent, Copyright, and Contract Analysis Compared
| Feature | Patent FTO | Copyright and data FTO | Contract and trade-secret FTO |
|---|---|---|---|
| Core question | Does a product practice enforceable patent claims? | May copying, training, storage, or outputs violate rights? | Do licenses, terms, confidentiality duties, or misuse rules restrict use? |
| Main evidence | Claims, specifications, prosecution history, status, assignments, and case law | Source and output evidence, licenses, registrations, fair-use or other defenses, and jurisdictional case law | Agreements, invoices, employee obligations, policies, access controls, and supplier terms |
The comparison shows why a patent-only report can miss central business risks. A company may have no apparent patent problem yet lack contractual permission to use a model-training corpus. Conversely, clear copyright compliance does not resolve a patent claim covering a specialized inference method. Contract review also matters because a vendor may offer broad patent or copyright representations while excluding combinations, customer-selected inputs, or outputs used to train competing systems. The strongest review assigns each issue to the right specialist and coordinates the conclusions.
Costs, Timing, and Practical Tiers
There is no responsible universal price for a generative AI FTO review. Cost depends on technical complexity, number of countries, number of model and service providers, breadth of patent searching, need for validity opinions, and the importance of the launch. A narrow question about one feature in one country may require only several thousand dollars. A multi-jurisdiction review of a multimodal platform, with several third-party models, custom training, retrieval, agents, and voice cloning, can cost tens of thousands of dollars and may require substantially more. Claim construction, validity analysis, technical expert work, and vendor negotiations often create most of the expense.
Timing should be planned backward from the business date, not treated as an automatic entitlement. A three-country preliminary landscape might be completed in 2–4 weeks when the product definition is stable. A focused pre-launch review involving one product family and 2–4 jurisdictions may take 4–8 weeks, while a global program involving multiple architectures can require 8–16 weeks. Those are planning ranges rather than legal guarantees. Emergency reviews can compress work, but they increase the risk of omitted continuations, unclear claim scope, and poor documentation.
Small teams can reduce cost without pretending that a cheap automated platform replaces legal review. A staged approach can begin with a product inventory, jurisdiction matrix, feature taxonomy, and high-level search. It can then pause for a technical checkpoint before spending on deep claim charts. A budget-conscious company might allocate 20% to definition and scoping, 25% to search and screening, 35% to technical claim analysis, and 20% to documentation and stakeholder review, although the actual allocation should reflect the product. The largest cost savings usually come from preventing late redesign, not from reducing legal standards.
AI contract terms deserve a specific check because the “indemnified loss” may be far narrower than the total exposure. A supplier might indemnify only specified third-party patent claims, exclude modified deployments, cap liability at 12 months of fees, or cover direct damages but not customer notification costs. Data licenses may permit model training but prohibit redistribution or use for standalone datasets. Teams should compare these terms with the launch value and architecture. If a supplier says its model is “open source,” counsel should identify the exact license and version because “open source” is not one uniform legal category.
Common FTO Mistakes and How Analysts Respond
One common mistake is treating a patent application as if it were an active patent. Applications can be abandoned, rejected, narrowed during prosecution, or superseded by another application in the same family. A search should verify current status and compare the asserted product feature with the granted claims, not merely the broadest abstract from an abstract screen. Another error is evaluating a product by its marketing label. “RAG,” “agent,” or “foundation model” can describe very different technical implementations, and claim analysis requires the actual operation of the system.
Companies also err by searching only in their home jurisdiction. Patent rights, copyright exceptions, contract rules, and remedies vary by country. A US clearance cannot be presented as European or Asian clearance. Conversely, companies sometimes overreact to the number of search hits, especially when results include expired patents, foreign filings with no target-country counterpart, or claims that do not cover the implementation. The number of potentially relevant documents is not a probability of invalidity. A meaningful ranking should consider jurisdiction, claim fit, ownership, remaining term, prosecution position, and evidence of enforceability.
A further mistake is postponing the work until a complaint arrives. At that point, the company may no longer know which dataset, model version, supplier terms, or configuration produced the product. Preservation of evidence becomes as important as redesign. A better trigger is the first decision to pilot externally, publish, license, acquire, or launch in a new country. For an early-stage company, a preliminary review at 2–3 months before an external pilot may be proportionate; a public launch usually warrants deeper review, and regulated uses such as clinical, financial, or safety-critical decisions justify specialist analysis before deployment.
When to Act and What Decision to Make
Act immediately when a product is about to be demonstrated to investors or customers under a non-confidential pilot, when a material component is supplied by a third party with unclear rights, or when a competitor has asserted a relevant claim. The immediate objective need not be to secure a final legal opinion. It may be to identify the affected feature, preserve documents, notify the relevant insurer or indemnitor if notice is required, and set a launch gate. The team should avoid sending admissions or deleting records while attempting an informal response.
For a new AI product, the practical launch gate should have at least four outcomes. “Proceed” means the review found no material unresolved issue on the stated facts. “Proceed with conditions” means a limited risk remains with an approved monitoring or contractual control. “Redesign” means a claim or contractual restriction is sufficiently relevant that changing the feature is preferable. “Escalate” means the issue requires senior counsel, a specialist, or a business decision about accepting uncertainty. This structure is more honest than a false green light and allows executives to understand why a delay or design change is justified.
The review should be refreshed after material model substitution, a new training dataset, a new country, a new customer category, an acquisition, or a change to outputs used in a regulated workflow. A 6–12 month cadence is reasonable for a stable product, but event-driven review is better for fast-moving systems. In 2026, organizations should also monitor the developing legal and policy environment around AI leadership, copyrighted works, training-data licensing, and human oversight. Political initiatives can influence agency priorities and proposed regulation, but they do not replace an analysis of enacted law and current case law. The best FTO process is therefore not a one-time certificate; it is a dated, auditable decision system for an AI product that continues to change.